Parvovirus B19 infection in pregnancy and subsequent morbidity and mortality in offspring

International Journal of Epidemiology

Volumn 42, Issue 4, 2013, Pages 1070-1076

  Lassen, Jonathan ^a   Bager, Peter ^a   Wohlfahrt, Jan ^a   Böttiger, Blenda ^a   Melbye, Mads ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

congenital abnormalities; Epidemiology; Infectious diseases; Morbidity; Mortality; Parvovirus

Indexed keywords

IMMUNOGLOBULIN M;

ABNORMALITY; AGE CLASS; CANCER; DATA QUALITY; EPIDEMIOLOGY; INFECTIOUS DISEASE; MORBIDITY; MORTALITY; PREGNANCY; RISK ASSESSMENT; SERUM; VIRAL DISEASE;

ARTICLE; CANCER RISK; CENTRAL NERVOUS SYSTEM; ENVIRONMENTAL EXPOSURE; ERYTHEMA INFECTIOSUM; FEMALE; FOLLOW UP; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; NEWBORN MORBIDITY; NEWBORN MORTALITY; PARVOVIRUS INFECTION; PREGNANCY; PREVALENCE; PRIORITY JOURNAL;

DENMARK;

PARVOVIRUS;

CONGENITAL ABNORMALITIES; EPIDEMIOLOGY; INFECTIOUS DISEASES; MORBIDITY; MORTALITY; PARVOVIRUS;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DENMARK; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MATERNAL AGE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL EXPOSURE DELAYED EFFECTS; YOUNG ADULT;

EID: 84884761041     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyt117     Document Type: Article

References (47)

1. Anderson MJ, Jones SE, Fisher-Hoch SP et al. Human parvovirus, the cause of erythema infectiosum (fifth disease)?. Lancet 1983;1:1378.
2. Anand A, Gray ES, Brown T, Clewley JP, Cohen BJ. Human parvovirus infection in pregnancy and hydrops fetalis. N Engl J Med 1987;316:183-86.
3. Brown T, Anand A, Ritchie LD, Clewley JP, Reid TM. Intrauterine parvovirus infection associated with hydrops fetalis. Lancet 1984;2:1033-34.
4. Brandenburg H, Los FJ, Cohen-Overbeek TE. A case of early intrauterine parvovirus B19 infection. Prenat Diagn 1996;16:75-77.
5. von Kaisenberg CS, Bender G, Scheewe J, et al. A case of fetal parvovirus B19 myocarditis, terminal cardiac heart failure, and perinatal heart transplantation. Fetal Diagn Ther 2001;16:427-32.
6. Enders M, Weidner A, Zoellner I, Searle K, Enders G. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn 2004;24:513-18.
7. Lassen J, Jensen AK, Bager P, et al. Parvovirus B19 infection in the first trimester of pregnancy and risk of fetal loss: a population-based case-control study. Am J Epidemiol 2012;176:803-07.
8. Miller E, Fairley CK, Cohen BJ, Seng C. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol 1998;105:174-78.
9. Chisaka H, Ito K, Niikura H, et al. Clinical manifestations and outcomes of parvovirus B19 infection during pregnancy in Japan. Tohoku J Exp Med 2006;209:277-83.
10. Gratacos E, Torres PJ, Vidal J, et al. The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome. J Infect Dis 1995;171: 1360-63.
11. De Jong EP, Lindenburg IT, van Klink JM, et al. Intrauterine transfusion for parvovirus B19 infection: long-term neurodevelopmental outcome. Am J Obstet Gynecol 2012;206:204-05.
12. Dembinski J, Haverkamp F, Maara H, Hansmann M, Eis-Hubinger AM, Bartmann P. Neurodevelopmental outcome after intrauterine red cell transfusion for parvovirus B19-induced fetal hydrops. BJOG 2002;109:1232-34.
13. Fairley CK, Smoleniec JS, Caul OE, Miller E. Observational study of effect of intrauterine transfusions on outcome of fetal hydrops after parvovirus B19 infection. Lancet 1995;346:1335-37.
14. Nagel HT, de Haan TR, Vandenbussche FP, Oepkes D, Walther FJ. Long-term outcome after fetal transfusion for hydrops associated with parvovirus B19 infection. Obstet Gynecol 2007;109:42-47.
15. Brown KE, Green SW, Antunez de MJ, et al. Congenital anaemia after transplacental B19 parvovirus infection. Lancet 1994;343:895-96.
16. Busby A, Dolk H, Armstrong B. Eye anomalies: seasonal variation and maternal viral infections. Epidemiology 2005; 16:317-22.
17. Hartwig NG, Vermeij-Keers C, van Elsacker-Niele AM, Fleuren GJ. Embryonic malformations in a case of intrauterine parvovirus B19 infection. Teratology 1989;39: 295-302.
18. Isumi H, Nunoue T, Nishida A, Takashima S. Fetal brain infection with human parvovirus B19. Pediatr Neurol 1999; 21:661-33.
19. Katz VL, McCoy MC, Kuller JA, Hansen WF. An association between fetal parvovirus B19 infection and fetal anomalies: a report of two cases. Am J Perinatol 1996; 13:43-45.
20. Morey AL, Keeling JW, Porter HJ, Fleming KA. Clinical and histopathological features of parvovirus B19 infection in the human fetus. Br J Obstet Gynaecol 1992;99:566-74.
21. Rogers BB, Mark Y, Oyer CE. Diagnosis and incidence of fetal parvovirus infection in an autopsy series: I. Histology. Pediatr Pathol 1993;13:371-79.
22. Suzuki N, Terada S, Inoue M. Neonatal meningitis with human parvovirus B19 infection. Arch Dis Child Fetal Neonatal Ed 1995;73:F196-97.
23. van Elsacker-Niele AM, Salimans MM, Weiland HT, Vermey-Keers C, Anderson MJ, Versteeg J. Fetal pathology in human parvovirus B19 infection. Br J Obstet Gynaecol 1989;96:768-75.
24. Weiner CP, Naides SJ. Fetal survival after human parvovirus B19 infection: spectrum of intrauterine response in a twin gestation. Am J Perinatol 1992;9:66-68.
25. Marton T, Martin WL, Whittle MJ. Hydrops fetalis and neonatal death from human parvovirus B19: an unusual complication. Prenat Diagn 2005;25:543-45.
26. Jordan EK, Sever JL. Fetal damage caused by parvoviral infections. Reprod Toxicol 1994;8:161-89.
27. Siegl G. Molecular biology and pathogenicity of human and animal parvoviruses. Behring Inst Mitt 1990;85:6-13.
28. Arpino C, Marzio M, D'Argenzio L, Longo B, Curatolo P. Exanthematic diseases during pregnancy and attentiondeficit/ hyperactivity disorder (ADHD). Eur J Paediatr Neurol 2005;9:363-65.
29. Fear NT, Roman E, Ansell P, Bull D. Malignant neoplasms of the brain during childhood: the role of prenatal and neonatal factors (United Kingdom). Cancer Causes Control 2001;12:443-49.
30. Linos A, Kardara M, Kosmidis H, et al. Reported influenza in pregnancy and childhood tumour. Eur J Epidemiol 1998;14:471-75.
31. McNally RJ, Eden TO. An infectious aetiology for childhood acute leukaemia: a review of the evidence. Br J Haematol 2004;127:243-63.
32. van der Werf N, Kroese FG, Rozing J, Hillebrands JL. Viral infections as potential triggers of type 1 diabetes. Diabetes Metab Res Rev 2007;23:169-83.
33. Xu B, Pekkanen J, Jarvelin MR, Olsen P, Hartikainen AL. Maternal infections in pregnancy and the development of asthma among offspring. Int J Epidemiol 1999;28:723-27.
34. Zipris D. Epidemiology of type 1 diabetes and what animal models teach us about the role of viruses in disease mechanisms. Clin Immunol 2009;131:11-23.
35. Pedersen CB, Gotzsche H, Moller JO, Mortensen PB. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 2006;53:441-49.
36. Bruu AL, Nordbo SA. Evaluation of five commercial tests for detection of immunoglobulin M antibodies to human parvovirus B19. J Clin Microbiol 1995;33:1363-65.
37. Cohen BJ, Bates CM. Evaluation of 4 commercial test kits for parvovirus B19-specific IgM. J Virol Methods 1995;55: 11-25.
38. Tolfvenstam T, Ruden U, Broliden K. Evaluation of serological assays for identification of parvovirus B19 immunoglobulin M. Clin Diagn Lab Immunol 1996;3:147-50.
39. Enders M, Helbig S, Hunjet A, Pfister H, Reichhuber C, Motz M. Comparative evaluation of two commercial enzyme immunoassays for serodiagnosis of human parvovirus B19 infection. J Virol Methods 2007;146:409-13.
40. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999;46:263-68.
41. Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry-history, content, quality and use. Dan Med Bull 1997;44:535-39.
42. Jensen IP, Thorsen P, Jeune B, Moller BR, Vestergaard BF. An epidemic of parvovirus B19 in a population of 3,596 pregnant women: a study of sociodemographic and medical risk factors. BJOG 2000;107: 637-43.
43. Valeur-Jensen AK, Pedersen CB, Westergaard T, et al. Risk factors for parvovirus B19 infection in pregnancy. JAMA 1999;281:1099-105.
44. Nielsen GL, Sorensen HT, Pedersen AB, Sabroe S. Analyses of data quality in registries concerning diabetes mellitus-a comparison between a population based hospital discharge and an insulin prescription registry. J Med Syst 1996;20:1-10.
45. Moth G, Vedsted P, Schiotz P. Identification of asthmatic children using prescription data and diagnosis. Eur J Clin Pharmacol 2007;63:605-11.
46. Ballou WR, Reed JL, Noble W, Young NS, Koenig S. Safety and immunogenicity of a recombinant parvovirus B19 vaccine formulated with MF59C.1. J Infect Dis 2003; 187:675-78.
47. Bernstein DI, El Sahly HM, Keitel WA, et al. Safety and immunogenicity of a candidate parvovirus B19 vaccine. Vaccine 2011;29:7357-63.